StockData
ResMed Inc logo

ResMed Inc

RMDNYSESurgical & Medical Instruments & ApparatusFiscal year ends June 30Also trades as RSMDF
Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 21/3011% below fair value
$242.61+4.76 (+2.00%)

Close on Nov 18, 2026Market cap $34.12BP/E 22.1Yield 0.99%

ResMed Rest of World Devices — Revenue Growth YoY by Quarter

Rest of World Devices — Revenue Growth YoY (%) (%)

Periods

ResMed Rest of World Devices — Revenue Growth YoY: 6.0% in Q1 FY27, down 5.0 pts from a year earlier.

Latest, Q1 FY27
6.0%
Period ended Sep 30, 2026 (CQ3 2026)
Change on a year earlier
-5.0 pts
11.0% in Q1 FY26
History
21 quarters
Since Q1 FY22
Sources
21
Documents cited below

Where the Q1 FY27 figure comes from

“Net revenue from devices for the three months ended September 30, 2026 increased to $720 million from $680 million for the three months ended September 30, 2025, an increase of $40 million or 6%, including an increase of 6% in the Americas and an increase of 6% in Rest of World (a 6% increase on a constant currency basis). Excluding the impact of foreign currency movements, device sales for the three months ended September 30, 2026 increased by 6”

Source: ResMed SEC Filing (0000943819-26-000089) ↗

Reported in ResMed Form 8-K Revenue by Product and Region Tables.

quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRest of World Devices — Revenue Growth YoY (%) (%)Year on yearSource
Q1 FY27CQ3 2026Sep 30, 20266.0%-5.0 ptsResMed SEC Filing (0000943819-26-000089) ↗
Q4 FY26CQ2 2026Jun 30, 202612.0%-2.0 ptsResMed SEC Filing (0001193125-26-337962) ↗
Q3 FY26CQ1 2026Mar 31, 202614.0%+8.0 ptsResMed SEC Filing (0001193125-26-197192) ↗
Q2 FY26CQ4 2025Dec 31, 20259.0%0.0 ptsResMed SEC Filing (0001193125-26-029326) ↗
Q1 FY26CQ3 2025Sep 30, 202511.0%+1.0 ptsResMed SEC Filing (0001193125-25-258519) ↗
Q4 FY25CQ2 2025Jun 30, 202514.0%+8.0 ptsResMed SEC Filing (0001193125-25-170512) ↗
Q3 FY25CQ1 2025Mar 31, 20256.0%+5.0 ptsResMed SEC Filing (0001193125-25-091357) ↗
Q2 FY25CQ4 2024Dec 31, 20249.0%-10.0 ptsResMed SEC Filing (0001193125-25-017218) ↗
Q1 FY25CQ3 2024Sep 30, 202410.0%-13.0 ptsResMed SEC Filing (0001193125-24-242806) ↗
Q4 FY24CQ2 2024Jun 30, 20246.0%-8.0 ptsResMed SEC Filing (0001193125-24-191487) ↗
Q3 FY24CQ1 2024Mar 31, 20241.0%-28.0 ptsResMed SEC Filing (0001193125-24-113883) ↗
Q2 FY24CQ4 2023Dec 31, 202319.0%+24.0 ptsResMed SEC Filing (0001193125-24-014223) ↗
Q1 FY24CQ3 2023Sep 30, 202323.0%+41.0 ptsResMed SEC Filing (0001193125-23-264072) ↗
Q4 FY23CQ2 2023Jun 30, 202314.0%+24.0 ptsResMed SEC Filing (0001193125-23-202850) ↗
Q3 FY23CQ1 2023Mar 31, 202329.0%+24.0 ptsResMed SEC Filing (0001193125-23-122110) ↗
Q2 FY23CQ4 2022Dec 31, 2022-5.0%-16.0 ptsResMed SEC Filing (0001193125-23-016231) ↗

Cite this data

StockData. (2026). ResMed Rest of World Devices — Revenue Growth YoY (%), quarterly Q1 FY22–Q1 FY27 [Data set]. Compiled from ResMed SEC filings and investor materials. https://stockdatahq.com/stocks/rmd/kpis/dev-row-yoy

See every metric in the ResMed KPI table. Data updated Nov 8, 2026.

See a number that looks wrong?